GRIA2 and Alzheimer disease: Consistent results were observed in postmortem cortical tissues from patients with AD, which exhibited significantly reduced GluA2 palmitoylation compared to cognitively normal controls, despite comparable total GluA2 protein levels (Fig. 6c).